Published in Stroke on February 23, 2012
Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg (2003) 6.05
Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg (2007) 4.95
MicroRNA-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitors. Cell Stem Cell (2010) 3.18
A simple clinical maneuver to reduce laparoscopy-induced shoulder pain: a randomized controlled trial. Obstet Gynecol (2008) 3.01
Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg (2014) 2.97
Family history of diabetes as a potential public health tool. Am J Prev Med (2003) 2.76
Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage. Stroke (2006) 2.68
Prevention of pain on injection of propofol: systematic review and meta-analysis. BMJ (2011) 2.38
Impact of meteorological conditions on the occurrence of acute type A aortic dissections. Interact Cardiovasc Thorac Surg (2009) 2.34
Aneurysm growth occurs at region of low wall shear stress: patient-specific correlation of hemodynamics and growth in a longitudinal study. Stroke (2008) 2.32
Validation of the Patient Health Questionnaire (PHQ)-9 for prenatal depression screening. Arch Womens Ment Health (2012) 2.26
Racial/Ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke (2007) 2.26
Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke (2003) 2.07
Temporal lobe arteriovenous malformations: anatomical subtypes, surgical strategy, and outcomes. J Neurosurg (2013) 2.02
A supplementary grading scale for selecting patients with brain arteriovenous malformations for surgery. Neurosurgery (2010) 2.01
Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci U S A (2007) 2.01
Silent arteriovenous malformation hemorrhage and the recognition of "unruptured" arteriovenous malformation patients who benefit from surgical intervention. Neurosurgery (2015) 1.99
Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann Neurol (2010) 1.96
A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting. Anesth Analg (2007) 1.94
Diagnostic accuracy of transesophageal echocardiography, helical computed tomography, and magnetic resonance imaging for suspected thoracic aortic dissection: systematic review and meta-analysis. Arch Intern Med (2006) 1.92
Critical roles of macrophages in the formation of intracranial aneurysm. Stroke (2010) 1.85
Weight, diet, and physical activity-related beliefs and practices among pregnant and postpartum Latino women: the role of social support. Matern Child Health J (2006) 1.84
Intracranial aneurysms: links among inflammation, hemodynamics and vascular remodeling. Neurol Res (2006) 1.81
Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape. J Exp Med (2004) 1.79
Essential regulation of CNS angiogenesis by the orphan G protein-coupled receptor GPR124. Science (2010) 1.79
Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol (2005) 1.78
Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke (2005) 1.78
A multiparameter panel method for outcome prediction following aneurysmal subarachnoid hemorrhage. Intensive Care Med (2009) 1.75
Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke (2004) 1.74
Reemergence of stroke deficits with midazolam challenge. Stroke (2002) 1.73
Biology of vascular malformations of the brain. Stroke (2009) 1.70
Evidence of inflammatory cell involvement in brain arteriovenous malformations. Neurosurgery (2008) 1.69
Experience of diffusion tensor imaging and 1H spectroscopy for outcome prediction in severe traumatic brain injury: Preliminary results. Crit Care Med (2009) 1.69
Minimal homozygous endothelial deletion of Eng with VEGF stimulation is sufficient to cause cerebrovascular dysplasia in the adult mouse. Cerebrovasc Dis (2012) 1.68
Does the left inferior longitudinal fasciculus play a role in language? A brain stimulation study. Brain (2007) 1.66
Superior outcomes in children compared with adults after microsurgical resection of brain arteriovenous malformations. J Neurosurg (2006) 1.66
Perioperative cognitive decline in the aging population. Mayo Clin Proc (2011) 1.66
Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage. Anesthesiology (2006) 1.64
S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage. Crit Care Med (2008) 1.61
Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage. Stroke (2005) 1.61
Arteriovenous malformation in the adult mouse brain resembling the human disease. Ann Neurol (2011) 1.55
Acute respiratory distress syndrome: lessons from computed tomography of the whole lung. Crit Care Med (2003) 1.54
Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture. Am J Epidemiol (2010) 1.53
Validation of in vivo magnetic resonance imaging blood-brain barrier permeability measurements by comparison with gold standard histology. Stroke (2011) 1.53
"Tangential" resection of medial temporal lobe arteriovenous malformations with the orbitozygomatic approach. Neurosurgery (2004) 1.53
Electrocautery interference with intraoperative electrocardiogram mimicking ST-segment depression. J Electrocardiol (2009) 1.52
Interleukin-6 involvement in brain arteriovenous malformations. Ann Neurol (2006) 1.51
Modification of the mitochondrial proteome in response to the stress of ethanol-dependent hepatotoxicity. J Biol Chem (2004) 1.51
Opposed effects of hypertonic saline on contusions and noncontused brain tissue in patients with severe traumatic brain injury. Crit Care Med (2006) 1.50
Correlation between lumenal geometry changes and hemodynamics in fusiform intracranial aneurysms. AJNR Am J Neuroradiol (2005) 1.50
Computational approach to quantifying hemodynamic forces in giant cerebral aneurysms. AJNR Am J Neuroradiol (2003) 1.49
Atorvastatin decreases computed tomography and S100-assessed brain ischemia after subarachnoid aneurysmal hemorrhage: a comparative study. Crit Care Med (2012) 1.45
Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain. J Cereb Blood Flow Metab (2004) 1.44
Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population. Stroke (2009) 1.44
Treatment and outcomes of ARUBA-eligible patients with unruptured brain arteriovenous malformations at a single institution. Neurosurg Focus (2014) 1.42
A quantitative computed tomography assessment of brain weight, volume, and specific gravity in severe head trauma. Intensive Care Med (2005) 1.41
Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro. J Cereb Blood Flow Metab (2007) 1.39
Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations. Stroke (2004) 1.39
Matrix metalloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral hemorrhage. Stroke (2007) 1.38
Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. AJNR Am J Neuroradiol (2004) 1.34
Macrophage imaging within human cerebral aneurysms wall using ferumoxytol-enhanced MRI: a pilot study. Arterioscler Thromb Vasc Biol (2012) 1.33
Doxycycline suppresses cerebral matrix metalloproteinase-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model. Stroke (2004) 1.33
Brain arteriovenous malformation pathogenesis: a response-to-injury paradigm. Acta Neurochir Suppl (2011) 1.32
Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice. Neurobiol Aging (2005) 1.32
High throughput two-dimensional blue-native electrophoresis: a tool for functional proteomics of mitochondria and signaling complexes. Proteomics (2002) 1.31
Phase-contrast magnetic resonance imaging measurements in intracranial aneurysms in vivo of flow patterns, velocity fields, and wall shear stress: comparison with computational fluid dynamics. Magn Reson Med (2009) 1.26
Coexpression of angiogenic factors in brain arteriovenous malformations. Neurosurgery (2005) 1.26
Hepcidin revisited, disulfide connectivity, dynamics, and structure. J Biol Chem (2009) 1.26
Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery (2004) 1.26
Brain arteriovenous malformation biology relevant to hemorrhage and implication for therapeutic development. Stroke (2008) 1.25
Increased tissue perfusion promotes capillary dysplasia in the ALK1-deficient mouse brain following VEGF stimulation. Am J Physiol Heart Circ Physiol (2008) 1.24
Relation between brain lesion location and clinical outcome in patients with severe traumatic brain injury: a diffusion tensor imaging study using voxel-based approaches. Hum Brain Mapp (2009) 1.24
MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations. Front Biosci (2006) 1.24
Recombinant adeno-associated viral vector encoding human VEGF165 induces neomicrovessel formation in the adult mouse brain. Front Biosci (2006) 1.23
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma. Neuro Oncol (2006) 1.23
VEGF Induces More Severe Cerebrovascular Dysplasia in Endoglin than in Alk1 Mice. Transl Stroke Res (2010) 1.23
Quantifying the use of bioresources for promoting their sharing in scientific research. Gigascience (2013) 1.22
Insulin growth factor-1 gene transfer enhances neurovascular remodeling and improves long-term stroke outcome in mice. Stroke (2008) 1.22
The ARUBA trial: current status, future hopes. Stroke (2010) 1.22
Effect of presenting hemorrhage on outcome after microsurgical resection of brain arteriovenous malformations. Neurosurgery (2005) 1.22
Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials. Arch Intern Med (2003) 1.21
Polymorphisms in transforming growth factor-beta-related genes ALK1 and ENG are associated with sporadic brain arteriovenous malformations. Stroke (2005) 1.21
Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor-induced smooth muscle cell migration: the role of ERK1/2, PI3K, and matrix metalloproteinases. Circ Res (2004) 1.20
Cerebellar arteriovenous malformations: anatomic subtypes, surgical results, and increased predictive accuracy of the supplementary grading system. Neurosurgery (2012) 1.20
Production of a novel class of polyreactive pathogenic autoantibodies in BXD2 mice causes glomerulonephritis and arthritis. Arthritis Rheum (2006) 1.20
Simvastatin enhances learning and memory independent of amyloid load in mice. Ann Neurol (2006) 1.19
Numerical simulations of flow in cerebral aneurysms: comparison of CFD results and in vivo MRI measurements. J Biomech Eng (2008) 1.18
Liquid chromatography tandem mass spectrometry identification of proanthocyanidins in rat plasma after oral administration of grape seed extract. Phytomedicine (2008) 1.18